DIMENSIONAL FUND ADVISORS LP - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$18,888,000
+112.7%
407,674
+11.9%
0.01%
+75.0%
Q1 2019$8,882,000
+7691.2%
364,393
+1038.1%
0.00%
Q2 2016$114,000
+11300.0%
32,019
+10573.0%
0.00%
Q2 2014$1,0000.0%3000.0%0.00%
Q1 2014$1,000
-50.0%
3000.0%0.00%
Q4 2013$2,0000.0%3000.0%0.00%
Q3 2013$2,000
+100.0%
3000.0%0.00%
Q2 2013$1,0003000.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders